These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36811648)

  • 1. [Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany].
    Scheithauer S; Dilthey A; Bludau A; Ciesek S; Corman V; Donker T; Eckmanns T; Egelkamp R; Grundmann H; Häcker G; Kaase M; Lange B; Mellmann A; Mielke M; Pletz M; Salzberger B; Thürmer A; Widmer A; Wieler LH; Wolff T; Gatermann S; Semmler T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Apr; 66(4):443-449. PubMed ID: 36811648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective.
    Salzberger B; Mellmann A; Bludau A; Ciesek S; Corman V; Dilthey A; Donker T; Eckmanns T; Egelkamp R; Gatermann SG; Grundmann H; Häcker G; Kaase M; Lange B; Mielke M; Pletz MW; Semmler T; Thürmer A; Wieler LH; Wolff T; Widmer AF; Scheithauer S
    Infection; 2023 Aug; 51(4):805-811. PubMed ID: 37129842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening pathogen genomic surveillance for health emergencies: insights from the World Health Organization's regional initiatives.
    Akande OW; Carter LL; Abubakar A; Achilla R; Barakat A; Gumede N; Guseinova A; Inbanathan FY; Kato M; Koua E; Leite J; Marklewitz M; Mendez-Rico J; Monamele C; Musul B; Nahapetyan K; Naidoo D; Ochola R; Ozel M; Raftery P; Vicari A; Wijesinghe PR; Zwetyenga J; Safreed-Harmon K; Barnadas C; Mulders M; Pereyaslov DI; Sacks JA; Warren T; Cognat S; Briand S; Samaan G
    Front Public Health; 2023; 11():1146730. PubMed ID: 37361158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North-South collaboration.
    Khan W; Kabir F; Kanwar S; Aziz F; Muneer S; Kalam A; Rajab Ali MN; Ansari N; Vanaerschot M; Ahyong V; Fahsbender L; Kalantar K; Black A; Glascock A; Gil J; Ayscue P; Tato C; Jehan F; Nisar I
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37984892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.
    Ling-Hu T; Rios-Guzman E; Lorenzo-Redondo R; Ozer EA; Hultquist JF
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DataHarmonizer: a tool for faster data harmonization, validation, aggregation and analysis of pathogen genomics contextual information.
    Gill IS; Griffiths EJ; Dooley D; Cameron R; Savić Kallesøe S; John NS; Sehar A; Gosal G; Alexander D; Chapel M; Croxen MA; Delisle B; Di Tullio R; Gaston D; Duggan A; Guthrie JL; Horsman M; Joshi E; Kearny L; Knox N; Lau L; LeBlanc JJ; Li V; Lyons P; MacKenzie K; McArthur AG; Panousis EM; Palmer J; Prystajecky N; Smith KN; Tanner J; Townend C; Tyler A; Van Domselaar G; Hsiao WWL
    Microb Genom; 2023 Jan; 9(1):. PubMed ID: 36748616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses.
    Rahman N; O'Cathail C; Zyoud A; Sokolov A; Oude Munnink B; Grüning B; Cummins C; Amid C; Nieuwenhuijse DF; Visontai D; Yuan DY; Gupta D; Prasad DK; Gulyás GM; Rinck G; McKinnon J; Rajan J; Knaggs J; Skiby JE; Stéger J; Szarvas J; Gueye K; Papp K; Hoek M; Kumar M; Ventouratou MA; Bouquieaux MC; Koliba M; Mansurova M; Haseeb M; Worp N; Harrison PW; Leinonen R; Thorne R; Selvakumar S; Hunt S; Venkataraman S; Jayathilaka S; Cezard T; Maier W; Waheed Z; Iqbal Z; Aarestrup FM; Csabai I; Koopmans M; Burdett T; Cochrane G
    Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38358325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing genomic epidemiology by addressing the bioinformatics bottleneck: Challenges, design principles, and a Swiss example.
    Chen C; Nadeau S; Topolsky I; Beerenwinkel N; Stadler T
    Epidemics; 2022 Jun; 39():100576. PubMed ID: 35605437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada's public health laboratories.
    Nadon C; Croxen M; Knox N; Tanner J; Zetner A; Yoshida C; Van Domselaar G
    BMC Public Health; 2022 Sep; 22(1):1817. PubMed ID: 36153510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global aircraft-based wastewater genomic surveillance network for early warning of future pandemics.
    Li J; Hosegood I; Powell D; Tscharke B; Lawler J; Thomas KV; Mueller JF
    Lancet Glob Health; 2023 May; 11(5):e791-e795. PubMed ID: 37061316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic epidemiology and phylogenetics applied to the study of SARS-CoV-2 pandemic.
    Lai A; Bergna A; Della Ventura C; Zehender G
    New Microbiol; 2023 Feb; 46(1):1-8. PubMed ID: 36853811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2.
    Moodley K; Cengiz N; Domingo A; Nair G; Obasa AE; Lessells RJ; de Oliveira T
    Lancet Glob Health; 2022 Dec; 10(12):e1855-e1859. PubMed ID: 36309034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Surveillance for Monitoring Variants of Concern: SARS-CoV-2 Delta, Omicron, and Beyond.
    Guest PC
    Methods Mol Biol; 2022; 2511():407-413. PubMed ID: 35838978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investing in health preparedness, response and resilience: a genomics costing tool focused on next generation sequencing.
    Akande OW; Afrough B; Amante M; Carter L; Cunningham J; Hull NC; Inamdar L; Jaguparov A; Marklewitz M; Musul B; Norberg A; Pereyaslov DI; Poates AL; Samaan G; Suresh A; Uplekar S; Wilhem A; Salvi Le Garrec Zwetyenga J; Whistler T
    Front Public Health; 2024; 12():1404243. PubMed ID: 38784596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the SARS-CoV-2 genomic data generation to evaluate the introduction of genomics in epidemiological surveillance and public health decision making.
    Souho T; Lamboni L; Bakadia BM; Taale E; Palanga KK; Amouzou SK
    Pan Afr Med J; 2022; 41():55. PubMed ID: 35317482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How public health authorities can use pathogen genomics in health protection practice: a consensus-building Delphi study conducted in the United Kingdom.
    Killough N; Patterson L; The Covid-Genomics Uk Cog-Uk Consortium ; Peacock SJ; Bradley DT
    Microb Genom; 2023 Feb; 9(2):. PubMed ID: 36745548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
    Bausewein C; Hodiamont F; Berges N; Ullrich A; Gerlach C; Oechsle K; Pauli B; Weber J; Stiel S; Schneider N; Krumm N; Rolke R; Gebel C; Jansky M; Nauck F; Wedding U; van Oorschot B; Roch C; Werner L; Fischer M; Schallenburger M; Reuters MC; Schwartz J; Neukirchen M; Gülay A; Maus K; Jaspers B; Radbruch L; Heckel M; Klinger I; Ostgathe C; Kriesen U; Junghanß C; Lehmann E; Gesell D; Gauder S; Boehlke C; Becker G; Pralong A; Strupp J; Leisse C; Schloesser K; Voltz R; Jung N; Simon ST;
    BMC Palliat Care; 2022 Jan; 21(1):10. PubMed ID: 35027041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany.
    Rodiah I; Vanella P; Kuhlmann A; Jaeger VK; Harries M; Krause G; Karch A; Bock W; Lange B
    Eur J Epidemiol; 2023 Jan; 38(1):39-58. PubMed ID: 36593336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global disparities in SARS-CoV-2 genomic surveillance.
    Brito AF; Semenova E; Dudas G; Hassler GW; Kalinich CC; Kraemer MUG; Ho J; Tegally H; Githinji G; Agoti CN; Matkin LE; Whittaker C; ; ; ; ; ; ; ; ; Howden BP; Sintchenko V; Zuckerman NS; Mor O; Blankenship HM; de Oliveira T; Lin RTP; Siqueira MM; Resende PC; Vasconcelos ATR; Spilki FR; Aguiar RS; Alexiev I; Ivanov IN; Philipova I; Carrington CVF; Sahadeo NSD; Branda B; Gurry C; Maurer-Stroh S; Naidoo D; von Eije KJ; Perkins MD; van Kerkhove M; Hill SC; Sabino EC; Pybus OG; Dye C; Bhatt S; Flaxman S; Suchard MA; Grubaugh ND; Baele G; Faria NR
    Nat Commun; 2022 Nov; 13(1):7003. PubMed ID: 36385137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.